Olanzapine Aurobindo

Olanzapine, the active ingredient in Olanzapine Aurobindo, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults. GNH USA supplies Olanzapine Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapine Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine is an atypical antipsychotic that modulates dopamine and serotonin pathways in several psychiatric conditions.

- Schizophrenia: helps control delusions, hallucinations and thought disorder. - Bipolar I disorder (manic episodes): reduces manic symptoms and stabilises mood. - Bipolar I disorder (depressive episodes): adjunctive therapy to improve depressive symptoms. - Schizoaffective disorder: alleviates both psychotic and mood components. - Psychotic depression: used as an adjunct to antidepressants for severe depressive episodes with psychotic features.

Olanzapine may produce a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Weight gain: increased appetite and caloric intake. - Sedation: drowsiness or feeling of being unusually tired. - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility. - Elevated triglycerides: rise in blood lipid levels. - Orthostatic hypotension: drop in blood pressure upon standing.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: persistent involuntary movements, often of the face. - Hyperglycaemia: significant rise in blood glucose, potentially precipitating diabetes. - Seizures: increased risk of convulsive episodes. - Agranulocytosis: marked reduction in white‑blood cell count. - Severe allergic reactions: anaphylaxis or Stevens‑Johnson syndrome.

When prescribing Olanzapine, clinicians should consider several safety aspects.

- Metabolic monitoring: regularly assess weight, fasting glucose and lipid profile. - Cardiovascular assessment: monitor blood pressure and heart rate, especially in patients with orthostatic tendencies. - CNS depression: caution when combined with other sedatives or alcohol. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Elderly patients: start at low dose and monitor for increased sedation. - Store at ambient temperature: keep in original packaging, protect from moisture.

Olenzol  

Major Interactions (Avoid): -  

Moderate Interactions (Monitor Closely):  -  

---

---  

---  """"  "  """  """" " " " "  " " ""  " ""  ""  ""  """  

--- 

--- 

--- ""